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When profiling hospital performance, quality inicators are commonly evaluated through hos-
pital-specific adjusted means with confidence intervals. When identifying deviations from a
norm, large hospitals can have statistically significant results even for clinically irrelevant
deviations while important deviations in small hospitals can remain undiscovered. We have
used data from the Swedish Stroke Register (Riksstroke) to illustrate the properties of a
benchmarking method that integrates considerations of both clinical relevance and level of
statistical significance.
Methods
The performance measure used was case-mix adjusted risk of death or dependency in
activities of daily living within 3 months after stroke. A hospital was labeled as having outly-
ing performance if its case-mix adjusted risk exceeded a benchmark value with a specified
statistical confidence level. The benchmark was expressed relative to the population risk
and should reflect the clinically relevant deviation that is to be detected. A simulation study
based on Riksstroke patient data from 2008–2009 was performed to investigate the effect
of the choice of the statistical confidence level and benchmark value on the diagnostic prop-
erties of the method.
Results
Simulations were based on 18,309 patients in 76 hospitals. The widely used setting, com-
paring 95% confidence intervals to the national average, resulted in low sensitivity (0.252)
and high specificity (0.991). There were large variations in sensitivity and specificity for dif-
ferent requirements of statistical confidence. Lowering statistical confidence improved sen-
sitivity with a relatively smaller loss of specificity. Variations due to different benchmark
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values were smaller, especially for sensitivity. This allows the choice of a clinically relevant
benchmark to be driven by clinical factors without major concerns about sufficiently reliable
evidence.
Conclusions
The study emphasizes the importance of combining clinical relevance and level of statistical
confidence when profiling hospital performance. To guide the decision process a web-
based tool that gives ROC-curves for different scenarios is provided.
Introduction
Measuring and monitoring performance is an essential component of quality improvement
strategies in health care. Assessments of hospital performance are widely used for both internal
guidance and evaluation purposes. They provide a basis for decisions by policy makers, health
care providers, and patients.
Several hospital performance and quality measurement systems have been implemented
worldwide, such as the National Peer Review Programme by the National Health Services
(NHS) in the UK [1], the World Health Organization’s Performance Assessment Tool for
Quality Improvement in Hospitals (PATH) [2], and The Centers for Medicare & Medicaid Ser-
vices’ Hospital Compare in the US [3]. In Sweden, a system of around 80 quality registers that
are jointly financed by the central government and county councils has been built to monitor
and improve the quality of care [4]. A majority of the registers provide publicly available com-
parisons of hospital quality-of-care parameters.
Several factors affect the precision of estimated hospital performance, including the choice
of performance measure, patient volume, the patient case-mix and its modeled impact, plus
simple random variation. Standard methods to report hospital performance include league
tables, forest plots, and funnel plots, displaying the means of an outcome or a process indicator
across hospitals. Their strengths and limitations have been extensively discussed [5–9]. Statisti-
cally significant deviations from a baseline such as the national average are typically seen as
indicators of outlying performance. Important deviations are then difficult to detect in small
hospitals, and in large hospitals such testing might point to outlying performance even for
small deviations that are not clinically relevant. Therefore, consideration needs to be given to
both the statistical properties of the decision criterion used to flag a hospital as outlying and to
the practical significance of the deviations that are flagged. The prevalent approach; focusing
on controlling the type I error rate to ensure that few hospitals are erroneously flagged, at the
cost of lower power to detect outliers, may be appropriate for some situations but not for oth-
ers. For decisions to have the desired impact, such as efficient allocation of resources, it is
important that deviations that are flagged are clinically relevant.
Developments have been and continue to be made in the area of health care quality assess-
ment, including the impact of using different types of performance measures [10, 11] and alter-
native statistical methods to address methodological issues such as small hospital size [12–15].
We examine the properties, including sensitivity and specificity, of a suggested benchmarking
method [13, 15] that considers what constitutes a clinically relevant deviation along with the degree
of statistical evidence required before labeling the deviation as relevant. This is done through a sim-
ulation study based on data from the Swedish Stroke Register (Riksstroke). We focus on the perfor-
mance indicator death or dependence in activities of daily living (ADL) at 3 months after stroke,
but the method is generally applicable to other outcomes and process indicators.
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The objective of this study is to support this important but complicated decision process by
highlighting the effect and relative importance of the choice of the benchmark value and
required statistical evidence level on the results. An Excel tool available online is provided to
guide the decision-making process in other settings.
Data and Methods
Data
The study was based on 18,309 patients registered in Riksstroke during the years 2008 and
2009. The patients included were 18–80 years old, were registered as having a first-time acute
stroke, and were independent in ADL at the time of stroke. The main purpose of Riksstroke is
to monitor and support improvement of quality of stroke care in Sweden [16]. It was estab-
lished in 1994 and covers all hospitals in the country that admit acute stroke patients (76 hospi-
tals in 2009). Information is collected during the acute phase and at follow-ups 3 months and 1
year after the stroke. In 2009, Riksstroke covered 85% of acute stroke cases, and just over 89%
of those registered during the acute phase were followed up at 3 months. For more details, see
the Riksstroke website http://www.riksstroke.org.
The performance indicator, dead or dependent in ADL at 3 months after stroke, was defined
as the patient being registered as dependent in ADL at the 3 month follow-up or the patient
dying within 3 months after stroke. Independence in ADL was defined as the patient being able
to manage dressing, using the toilet, and walking indoors unassisted. Dates of death were
retrieved for all patients from the Swedish Cause of Death Register managed by the National
Board of Health and Welfare using the Swedish personal identification number. Thus patients
with missing outcomes were those that were alive but did not provide follow-up information at
3 months after their stroke.
Baseline patient characteristics were used for case-mix adjustments. The clinically most
important predictors of death or ADL dependency were included: age, sex, level of conscious-
ness at admission, stroke subtype, smoking status, atrial fibrillation, and diabetes. The level of
consciousness at admission to the hospital was used as a proxy for stroke severity. It was regis-
tered using three levels based on the Reaction Level Scale (RLS) [17] where fully conscious cor-
responds to RLS 1, drowsy to RLS 2–3, and unconscious to RLS 4–8. Stroke subtypes were
intra-cerebral hemorrhagic (ICD-10 code I61), ischemic (I63), and unspecified stroke (I64).
Smoking status was coded as Yes/No/Unknown due to a large proportion of missing informa-
tion on baseline smoking status.
All patients and their next of kin are informed about registration in the quality register Riks-
stroke, that the aim of the register is to support high and consistent quality of care for stroke
patients throughout Sweden, and that data may be used for developing and ensuring the quality
of stroke treatment, for compiling statistics and for health care research purposes. They are
informed of their rights to deny participation (opt-out consent). Consent is not collected for
specific research projects in addition to this general consent. Participation in this project
involves no direct risk for the patients. Data were de-identified prior to being received by the
researchers. Riksstroke in general (reference number 95–168) and this project (212-321-31M)
has been approved by the Regional Ethical Review Board in Umeå.
Statistical method for case-mix adjustment
We used direct standardization to adjust the outcome for differences in patient case-mix over
hospitals. A hospital-specific standardized risk of death or dependency, Rh, then estimates the
risk expected across the entire study population should all patients receive the level of care
offered at hospital h. Each hospital is thus evaluated on a common reference population.
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Several estimators exist for these hospital-specific risks, and the relative performance of dif-
ferent modelling approaches for case-mix adjustment, such as fixed versus random hospital
effects, has been evaluated in the context of provider profiling.[13, 18, 19] Following recom-
mendations in [15], we start from a fixed effects multiple logistic regression model, adding the










Ih  ch; ð1Þ
where pi is the risk of death or dependence for patient i and β is the vector of regression param-
eters associated with the patient speciﬁc covariates X. Ih is an indicator variable that takes value
1 if patient i was treated in hospital h and 0 otherwise, and ψh is the hospital effect for hospital
h. We assume that the hospital effects are constant regardless of the patient-speciﬁc covariate
values and thus no hospital-covariate interactions are included in the model. It has been shown
that our inference is robust against violations of this assumption (see discussion).
If the covariates in X are sufficient to adjust for case-mix, we can estimate Rh by replacing
the sum in Eq 1 for all patients with the estimated hospital effect for hospital h, ψh, regardless
of where they were actually treated. Let us define the risk of patient i under the care level of hos-
pital h as pih. Suppose for simplicity that we need to adjust for age only. Logistic regression
then models the risk of patient i being dead or dependent at 3 months under the potential care





¼ b0 þ b1ðAge of patient iÞ þ ch; ð2Þ
where β1 is the increase in log-odds per one-year increase in age. Note that the hospital effect
has been ﬁxed to ψh regardless of where patient i was actually treated.
The standardized risk for hospital h, Rh, is then the average of pih over all n patients. This
standardized risk can be interpreted as the estimated proportion of patients being dead or
dependent if all had received the same quality of care as that of hospital h. For a more formal
description of the standardization, see section 1 of S1 Appendix.
Decision criterion
Quality control is often concerned with detecting underperforming hospitals. For our outcome
this means a focus on high outliers, and we aim to diagnose hospital-specific risks exceeding
the current population risk by a meaningful margin. Consensus among the clinical expertize
should be the basis for the maximum tolerated value of the hospital-specific risk Rh. This value
will further depend on the study purpose and foreseeable implications of the hospitals’ screen-
ing results. An early warning signal privately delivered to the hospital should be less conserva-
tive than a formally published diagnosis of the hospital crossing the benchmark. For our
scientific work we chose to express the benchmark risk through a parameter δ, the relative
increase of the current population risk. We thus have (1 + δ) times the observed population
risk as the benchmark for Rh. For example, a hospital-specific standardized risk may be clini-
cally acceptable as long as it does not exceed the population risk by more than 20%. With δ =
0.20 and an observed population risk of 25% the benchmark becomes (1.20 × 0.25), corre-
sponding to a 30% hospital-specific standardized risk.
Identifying hospitals with excess risk from a sample of patients needs a decision process that
accounts for sampling variation and resulting uncertainty. Available statistical information is
commonly summarized through the confidence interval for the standardized risk. Accordingly,
hospital hmay be classified as outlying when we are k x 100% certain that the true hospital-
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specific standardized risk Rh, exceeds the benchmark value. [12, 13, 15] Technically we then
check whether the (lower bound) of the k × 100% one-sided confidence interval for Rh exceeds
(1 + δ) times the observed population risk. Calculation of this CI can be based on a normal
approximation, as shown by Varewyck, Goetghebeur (15]. Part 2 of S1 Appendix describes the
derivation of the variance of the estimated Rh.
For a given benchmark (a given δ), patient case-mix and risk setting, the chosen confidence
level k will determine the sensitivity and specificity of our hospital diagnoses.
Simulations
The properties of the proposed method were investigated through a simulation study mimick-
ing the data structure found in Riksstroke. The model (1) fitted to the original Riksstroke data
associates a predicted risk with each patient’s covariate values. We randomly generated inde-
pendent binary outcomes following these risks to create 1000 new simulated data sets.
Next, we analyzed each simulated data set as if it were the original one. From its observed
population risk we found the simulation-specific benchmark. After refitting the logistic regres-
sion model we derived the corresponding standardized risk for hospital h, Rsh, from each simu-
lated data set s. When its k × 100% one-sided CI exceeded the benchmark, hospital h was
labeled with excess risk for simulation s. Otherwise the hospital was labeled as having accept-
able performance. So for a chosen confidence level k and a given margin of excess risk δ, 1000
diagnoses were derived for each of the 76 hospitals. The simulation algorithm is outlined in
section 3 of the S1 Appendix.
The 1000 simulated classifications were then compared to the gold standard, the classifica-
tions obtained from the original Riksstroke data. A hospital h was classified as having true
excess risk in the simulated setting when its standardized risk Rh from the original logistic
regression fit exceeded the benchmark, (1 + δ) times the originally observed population risk.
We could thus calculate the percentage correctly classified hospitals over all simulated data
sets as well as sensitivity, specificity, and positive and negative predictive values (PPV and
NPV, respectively) for the decision process. This was done for selected levels of confidence,
with k ranging from 0.01 (low) to 0.99 (high) and for benchmark values corresponding to δ =
0, 0.10, 0.15, and 0.20. Benchmarks hence varied from the observed population risk to a 20%
relative increase.
Simulations and analyses were performed using the R 2.15.2 software environment (The R
Foundation for Statistical Computing).
Results
Original data
Of the 21,376 patients that met the inclusion criteria, 2,788 (13.0%) were lost to follow-up at 3
months, and another 279 (1.3%) had missing information for one or more covariates other
than smoking status. The group that lacked data on the 3 month follow-up was on average
younger and included a slightly larger proportion of patients with hemorrhagic stroke, a larger
proportion of smokers, and a smaller proportion of patients with atrial fibrillation (see
Table 1). For the purpose of our illustration here, cases with missing data, except for the large
patient group with missing smoking status, were deleted, leaving a total of 18,309 patients in
the study.
Time from stroke to the scheduled ‘3 month’ follow-up varied with a median of 91 days and
95% of the follow-ups occurred between 74 and 153 days. All these follow-up data were
included. At the 3 month follow-up 22.0% of patients (95% CI: 21.4–22.6%) had died or were
dependent in ADL. Over the 76 hospitals, the median number of patients was 194 (range 27–
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798 patients) with observed risks of death or dependency ranging from 8.8% to 37.0%, as illus-
trated by the caterpillar plot in Fig 1.
Most hospitals had a similar case-mix with the exception of a few extreme hospitals (see
Table 2). For example, the average patient ages among the hospitals had a median of 68.4 years,
Table 1. Patient characteristics grouped by availibity of three month follow-up.
With follow-up (n = 18,309) Lost to follow-up (n = 2,788)
Covariate Mean/Proportion Standard error Mean/Proportion Standard error
Age (Years) 67.6 0.07 64.7 0.23
Male sex 58.9% 0.36% 61.0% 0.92%
Level of consciousness
Alert 87.8% 0.24% 87.1% 0.64%
Drowsy 8.3% 0.20% 9.9% 0.57%
Unconscious 3.9% 0.14% 3.0% 0.32%
Subtype
Hemorrhagic 13.1% 0.25% 15.5% 0.69%
Ischemic 84.9% 0.26% 81.9% 0.73%
Unspeciﬁed 2.0% 0.10% 2.6% 0.30%
Smoking
No 72.5% 0.33% 63.8% 0.91%
Yes 20.0% 0.30% 23.7% 0.81%
No information 7.4% 0.19% 12.5% 0.63%
Atrial ﬁbrillation 18.2% 0.29% 16.2% 0.70%
Diabetes 19.6% 0.29% 19.2% 0.75%
doi:10.1371/journal.pone.0153082.t001
Fig 1. Caterpillar plot of the proportion dead or dependent 3 months after stroke with 95% confidence
intervals for each hospital. The dashed line represents the observed population risk (based on 18,309
patients).
doi:10.1371/journal.pone.0153082.g001
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but the lowest average age for an individual hospital was 60.6 years. The proportion of patients
who were fully conscious at arrival ranged from 73.3% to 95.1%.
Multiple logistic regression showed that older age, female sex, lower level of consciousness
at admission, atrial fibrillation, diabetes, smoking, and hemorrhagic stroke were associated
with significantly higher risk of death or dependence (Table 3). The estimated odds ratios com-
paring individual hospital risks to the average over all hospitals after adjustment for case-mix
(i.e. using effects coding) ranged from 0.3 to 1.8 with a majority in the 0.8–1.2 range (Fig 2A).
Comparing hospital-specific risks to the (1 + δ) times (observed population risk) bench-
mark lead to 40 (22, 12, and 7, respectively) out of the 76 hospitals exceeding the benchmark
for δ = 0 (0.10, 0.15, 0.20), i.e. 22.0% (24.2%, 25.3%, 26.4%) risk at 3 months. Fig 2B shows a
histogram of the hospital-specific standardized risks with lines marking the different bench-
mark values.
Diagnostic properties of the method for identifying outlying performance
Sensitivity and specificity reflect the method’s ability to correctly classify hospitals with excess
risk or acceptable levels of care. Table 4 shows results for the different benchmarks (δ) and
selected levels of statistical confidence (k). These are summarized in ROC curves in Fig 3A. For
a given benchmark value (i.e. a given δ), demanding more evidence (k) before labeling a hospi-
tal as ‘outlying’ naturally leads to fewer positive decisions irrespective of the truth and therefore
lower sensitivity and increased specificity.
On the other hand, seeking to diagnose fewer hospitals with more severe levels of excess
risk, i.e. increasing δ while keeping the demanded confidence level k fixed, has less obvious
implications for the diagnostic properties of our procedure. Sensitivity depends on the distribu-
tion of the hospital-specific risks above the benchmark, shown in Fig 2B. Hospitals which
exceed the benchmark with a greater margin will be easier to detect, even if they are relatively
small in size. In our case, a higher δ led to little change in sensitivity (in either direction) while
specificity tended to increase. This meant the ROC curve hardly changed in height (sensitivity)
but shifted to the left (changing specificity) as illustrated for k = 0.25 and k = 0.5 in Fig 3A. The
Table 2. Patient characteristics (means and proportions) at the hospital level.
Covariate Min Q1 Median Q3 Max
Dead or dependent at 3 months 8.8% 19.2% 22.1% 25.2% 37.0%
Age (Years) 60.6 67.3 68.4 69.0 72.6
Male sex 50.6% 56.8% 58.5% 61.5% 69.5%
Level of consciousness
Alert 73.3% 85.4% 88.6% 91.1% 95.1%
Drowsy 3.0% 6.0% 7.9% 10.3% 18.3%
Unconscious 0.0% 2.2% 3.5% 4.9% 13.3%
Subtype
Hemorrhagic 5.1% 10.1% 12.7% 15.1% 27.0%
Ischemic 64.6% 82.2% 85.2% 88.4% 94.9%
Unspeciﬁed 0% 0% 1.2% 2.9% 27.2%
Smoking
No 48.1% 68.7% 73.3% 77.7% 84.2%
Yes 12.0% 16.0% 19.1% 21.3% 31.6%
No information 0.0% 3.5% 6.1% 11.9% 37.0%
Atrial ﬁbrillation 11.6% 16.5% 18.3% 20.0% 31.2%
Diabetes 10.5% 17.7% 19.8% 22.4% 31.2%
doi:10.1371/journal.pone.0153082.t002
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stability of the sensitivity indicates that concerns about sufficiently reliable evidence should not
influence the choice of a clinically relevant benchmark.
For a given benchmark value (δ) the positive predictive value, PPV, increased and the nega-
tive predictive value, NPV, decreased with increasing k (Fig 3B.). Because more evidence was
required to be labeled ‘outlying’, the risk of being wrongly classified as such decreased and, con-
versely, the risk of being wrongly classified as ‘acceptable’ increased.
Again, determining the choice of k that gives a desired PPV or NPV is not straightforward,
and this choice is affected by the distribution of the standardized hospital risks in the observed
hospital population. In our setting, increasing δ (while keeping k fixed) decreased the PPV and
increased the NPV (Fig 3B.). A higher benchmark leads to a larger number of truly ‘acceptable’
hospitals that run the risk of being wrongly classified as ‘outlying’ leading in turn to a tendency
for a lower PPV.
As a concluding example, using the “standard”method with 95% confidence compared to the
overall average (k = 0.95 and δ = 0) gave a sensitivity of 0.252 and a specificity of 0.991 (marked
with a diamond in Fig 3A.). That is, the accuracy of identifying ‘acceptable’ performers was high,
but the accuracy of identifying ‘outlying’ performers was quite low. By choosing k = 0.5, we
obtained a sensitivity of 0.769 and a specificity of 0.813 meaning a relatively high accuracy in
identifying both types of hospitals. Focusing on the predictive values, the standard method gave
PPV = 0.967 and NPV = 0.544. This means that a classification as ‘outlying’ is likely to reflect the
true performance of the hospital, while an ‘acceptable’ classification only reflects the true state of
the hospital in just over half of all cases. A choice of k = 0.5 gave PPV = 0.820 and NPV = 0.760.
Table 3. Estimated effects frommultiple logistic regression modeling death or dependency at 3 months. Presented with estimated standard errors
(SE), odds ratios (OR) and confidence intervals (CI).
Estimated SE Estimated OR 95% CI P-value
β of OR
Intercept −4.495 0.183 0.011 [0.008; 0.016] <0.001
Age 0.048 0.002 1.050 [1.045; 1.055] <0.001
Sex 0.016
Female Reference
Male −0.101 0.042 0.904 [0.833; 0.981]
Level of consciousness at admission <0.001
Alert Reference
Drowsy 2.075 0.061 7.964 [7.060; 8.984]
Unconscious 3.336 0.115 28.108 [22.441; 35.207]
Type of stroke <0.001
Hemorrhagic Reference
Ischemic −0.870 0.057 0.419 [0.375; 0.469]
Unspeciﬁed −1.078 0.167 0.340 [0.245; 0.472]
Smoking <0.001
No Reference
Yes 0.162 0.055 1.176 [1.056; 1.309]
No information 0.551 0.074 1.734 [1.501; 2.004]
Atrial ﬁbrillation <0.001
No Reference
Yes 0.378 0.050 1.459 [1.323; 1.609]
Diabetes <0.001
No Reference
Yes 0.422 0.049 1.525 [1.385; 1.678]
doi:10.1371/journal.pone.0153082.t003
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Discussion
We have illustrated the characteristics of a method for benchmarking hospital performance
that integrates statistical evidence with what is considered to be a clinically relevant deviation.
With the standard method, comparing 95% confidence intervals to the overall average, less
than 1% of hospitals with acceptable performance would be erroneously flagged (high specific-
ity). However, in this scenario, 75% of hospitals with outlying performance would remain
undetected (low sensitivity). Decreasing the level of statistical evidence required to label a hos-
pital as having outlying performance had the expected effects of increasing sensitivity and
decreasing specificity. The effect of choosing a higher benchmark value was less obviously
anticipated. Sensitivity is the ratio of the number of correctly identified outliers to the total
number of outlying hospitals and both the numerator and denominator change with the
benchmark value. These dynamics are affected by the shape of the upper tail of the distribution
of the standardized risks. Specificity was not affected in the same way by these dynamics, and it
increased predictably with increasing benchmark values. This is, however, not automatically
Fig 2. a: Hospital effects (odds ratios) from the logistic regression model (each individual hospital compared to the average over all hospitals). b:
Standardized risks (original data) with lines for the benchmark values ((1 + δ) observed population risk) for different values of δ.
doi:10.1371/journal.pone.0153082.g002
Table 4. Sensitivity and specificity for different values of acceptable deviation (δ) and statistical evidence (k).
δ = 0 δ = 0.1 δ = 0.15 δ = 0.2
k × 100 (%) Sens. Spec. Sens. Spec. Sens. Spec. Sens. Spec.
10 0.963 0.478 0.948 0.570 0.950 0.604 0.957 0.667
30 0.879 0.686 0.835 0.761 0.846 0.782 0.857 0.827
50 0.769 0.813 0.693 0.869 0.707 0.881 0.718 0.909
75 0.565 0.928 0.453 0.956 0.463 0.958 0.471 0.970
90 0.359 0.977 0.257 0.988 0.259 0.988 0.244 0.992
99 0.112 0.999 0.062 0.999 0.053 0.999 0.038 1.000
doi:10.1371/journal.pone.0153082.t004
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the case. For example, one might simultaneously be interested in identifying hospitals that per-
form better than expected, which would give three-way classifications. Then the lower tail of
the distribution of standardized risks would also have an effect.
Fig 3. a: ROC curves for different values of δ and k based on 1000 simulations. b: Positive (solid lines) and
negative (dashed lines) predictive values for different values of k and δ based on 1000 simulations.
doi:10.1371/journal.pone.0153082.g003
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General recommendations regarding an optimal choice of level of evidence k cannot be pro-
vided because these are specific to the purpose of the comparison and the quality indicator. To
help with these decisions, we have provided an Excel tool “Web tool ROC” (available at http://
www.riksstroke.org/software/). In this tool, the user can insert relevant hospital risks (e.g. the
standardized risks with their standard errors from the previous year) and select a benchmark
by providing a value of δ. The theoretical sensitivities and specificities that result from different
values of statistical confidence are then calculated and summarized through ROC curves.
The Swedish National Board of Health and Welfare profiles health care performance based
on rankings according to a hospital’s position relative to others (low, mid, and top tertile) [20].
The NHS uses target levels,[1] and Riksstroke uses objectively defined values for acceptable
and high performance [21]. Here, we used a benchmark that is relative to the average national
hospital performance and includes a clinically relevant deviation. Hence, the drawback with
relative rankings that always identify the same number of hospitals regardless of the general
level of performance is avoided, and at the same time the general level of care is accounted for
and hence allowed to change over time as new treatments become available or the population
grows older. An added advantage is that the flexibility of the benchmark allows a change in set-
ting, e.g., to a specific disease subtype or to a subgroup of the population. The decision of the
benchmark is made by clinicians, e.g., through Delphi processes and consensus groups.
The hospitals in our application had similar case-mix, and for an acute illness such as stroke
it can be argued that all hospitals should be able to treat the same type of patients rather than
being specialized for a certain patient group. Therefore, adjustment for case-mix was per-
formed using direct standardization by comparing hospitals based on the entire study popula-
tion rather than indirect standardization where hospitals are evaluated based on their own
patients. This facilitates straightforward national comparisons and joint benchmark values for
policy makers because hospitals are evaluated against the same reference population, and the
potential lack of comparability with non-overlapping case-mix in indirect standardization is
avoided [22, 23]. In a different set-up a parallel development may be followed for indirect
standardization.
The logistic regression model used here was kept simple, since the goal of the paper is to
illustrate the method and not to make inferences about this particular outcome. The model
could be extended to include additional covariates and interactions, e. g., hospital-covariate
interactions to allow the hospital effects to vary across covariate values. The assumption of con-
stant hospital effects would be violated e.g. when some hospitals are better than others at treat-
ing geriatric patients. Reassuringly, [24] showed that ignoring an existing hospital interaction
has negligible impact when, as in our setting, the variation in patient case-mix is mild. For situ-
ations with small hospitals more sophisticated modelling approaches could be applied to avoid
bias [15]. Variables that are important to include in case-mix adjustment of stroke outcome for
hospital comparisons have recently been suggested [25], and an important variable is stroke
severity [25, 26]. Our study included consciousness at hospital admission as a proxy for stroke
severity and for example did not include prior myocardial infarction or hyperlipidemia, which
might cause residual confounding.
When deciding on a benchmarking approach it is important to take into account the pur-
pose of the benchmarking. Will the results be used for internal or external purposes? Is it more
important to have a procedure with low chance of missing outlying hospitals (high sensitivity)
than one with low chance of wrongly classifying hospitals as outlying (high specificity)? The
“standard” method with 95% confidence compared to the overall average seems to be useful
only in the latter setting, having a very high specificity at the cost of missing a large portion of
hospitals with outlying performance. With a focus on predictive values we want to know
whether a classification as having outlying/acceptable performance is likely to reflect the true
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performance of the hospital. These considerations affect the choice of the optimal statistical
confidence level. The aforementioned web-based tool can be used to guide policy makers when
making the necessary choices.
Conclusions
We have emphasized the importance of integrating clinical and statistical evidence when evalu-
ating hospital performance and have studied the properties of a targeted method that achieves
this goal in the context of the Swedish Stroke Register. The statistical confidence level used
affects the balance between sensitivity and specificity depending on which deviation we seek to
discover in the hospital population. A good choice will account for the purpose of the bench-
marking and the context in which the results of the benchmarking will be used.
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